It is a cancer drug her company discovered—one that has made her the face of a rising pharmaceutical star. When Xia founded ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

International: Capivasertib, a breakthrough drug for advanced HR-positive HER2-negative breast cancer, has been approved by ...

A new research perspective was published in , Volume 16, on April 4, 2025, titled "GSK3β activation is a key driver of ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...

A tiny protein at the center of Parkinson’s disease also plays a surprising role in melanoma, a dangerous skin cancer. New ...

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say they have found a new role for a protein, ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois Urbana ...

Cipla has secured USFDA approval to market a generic cancer treatment, specifically paclitaxel protein-bound particles.

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...